Evidence map›Paper›PMID 31744816›Full record

ArticleCancer research2020

Beclin 1 Promotes Endosome Recruitment of Hepatocyte Growth Factor Tyrosine Kinase Substrate to Suppress Tumor Proliferation.

Asia N Matthew-Onabanjo, Jenny Janusis, Jose Mercado-Matos, Anne E Carlisle, Dohoon Kim, Fayola Levine, Peter Cruz-Gordillo, Ryan Richards, Michael J Lee, Leslie M Shaw

Abstract read
In one paragraph

Article in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Targeting protein-protein interactions in the BCL-2 family: opportunities for precision oncology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Insights into the Structural and Proteomic Changes inAnimals : an open access journal from MDPI · 2025
    Article
  6. The Biological Role and Clinical Significance of BECLIN-1 in Cancer.International journal of molecular sciences · 2025
    Review
  7. Review
  8. A CMTM6 Nanobody Overcomes EGFR-TKI Resistance in Non-Small Cell Lung Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. The Role of Non-Coding RNAs in Autophagy During Carcinogenesis.Frontiers in cell and developmental biology · 2022
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Asia N Matthew-OnabanjoDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts.ORCID 0000-0003-4803-5926
Jenny JanusisDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts.
Jose Mercado-MatosDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts.
Anne E CarlisleDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts.
Dohoon KimDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts.ORCID 0000-0002-5723-6589
Fayola LevineDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts.
Peter Cruz-GordilloMedical Scientist Training Program, University of Massachusetts Medical School, Worcester, Massachusetts.
Ryan RichardsProgram in Systems Biology, University of Massachusetts Medical School, Worcester, Massachusetts.
Michael J LeeProgram in Systems Biology, University of Massachusetts Medical School, Worcester, Massachusetts.ORCID 0000-0003-3378-6196
Leslie M ShawDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts. leslie.shaw@umassmed.edu.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Translational Cancer Biology Training ProgramT32CA130807 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MERCURIO, ARTHUR M · 2008 to 2018
$2.7M
Autophagy-independent function of Beclin 1 in Breast CancerR01CA177167 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SHAW, LESLIE M · 2013 to 2017
$1.9M
Impact of Beclin 1 Loss on Breast Cancer ProgressionF31CA206378 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MATTHEW, ASIA · 2016 to 2019
$97k
NCI NIH HHS F31 CA206378NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA177167NCI NIH HHS T32 CA130807
6 · The paper itself

Abstract

Beclin 1 has nonautophagic functions that include its ability to regulate endocytic receptor trafficking. However, the contribution of this function to tumor suppression is poorly understood. Here, we provide

Indexed as

Antigens, CDBeclin-1Cell Line, TumorCell ProliferationDisease ProgressionEndosomal Sorting Complexes Required for TransportEndosomesErbB ReceptorsHumansNeoplasmsPhosphoproteinsReceptors, TransferrinAntigens, CDBeclin-1BECN1 protein, humanCD71 antigenEGFR protein, humanEndosomal Sorting Complexes Required for TransportErbB Receptorshepatocyte growth factor-regulated tyrosine kinase substratePhosphoproteinsReceptors, Transferrin

Identifiers

PMID31744816
PMCPMC6980665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.